In summary, our results demonstrated that Sf9 cell-derived chimeric VLPs, comprised of the HIV-1 Gag matrix protein and the cancer antigen HER2, had potent effects of inducing durable humoral and cellular immune responses in vivo. This evidence concerns the gene ERBB2 and cancer.